In its fourth-quarter 2022 financial results, Lilly said the growth was driven by increased demand, partially offset by lower realized prices. Outside the US, revenue was $409.8 million, a decrease of six percent, which the company said was driven by the unfavorable impact of foreign exchange rates and to a lesser extent, lower realized prices, partially offset by increased demand. But on a constant currency basis, non-US revenue increased eight percent
The samples were left to react for 10 min before the solution was quenched with 10 l of formic acid
Prioritizing protein content, fat, calorie, and sugar reduction while boosting the nutritional value of products will be essential
Significant Potential for Indication Expansion to Address Diverse Needs In the vast field of pharmaceutical research, NA-931, as a highly innovative four target agonist, is shining with unique brilliance